TRABEKTEDIN STADA
Powder for concentrate for solution for infusion, 0.25mg
RxActive license
Active substance (INN)
trabectedin
Pharmaceutical form
Pharmaceutical formPowder for concentrate for solution for infusion
Strength0.25mg
PackagingUkupno 1 bočica staklena sa praškom za koncentrat za rastvor za infuziju u kartonskoj kutiji
ManufacturerStada Arzneimittel AG, Germany
Therapeutic groupAntineoplastic and immunomodulating agents (L01CX01)
Marketing authorization holderHEMOFARM A.D. VRŠAC P.J. PODGORICA
Authorization dateJuly 31, 2025
Analogs in Montenegro
1Other medicines with the same active substance
Source: CInMED register